Report Overview
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
The global Cold Chain Services for Innovative Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
Analytic Insights Hub' newest research report, the “Cold Chain Services for Innovative Drug Industry Forecast” looks at past sales and reviews total world Cold Chain Services for Innovative Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Cold Chain Services for Innovative Drug sales for 2023 through 2029. With Cold Chain Services for Innovative Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold Chain Services for Innovative Drug industry.
This Insight Report provides a comprehensive analysis of the global Cold Chain Services for Innovative Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cold Chain Services for Innovative Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold Chain Services for Innovative Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold Chain Services for Innovative Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold Chain Services for Innovative Drug.
United States market for Cold Chain Services for Innovative Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cold Chain Services for Innovative Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cold Chain Services for Innovative Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cold Chain Services for Innovative Drug players cover Marken, World Courier, Cryoport, DTW Logistics, City Express, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cold Chain Services for Innovative Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
International Transportation
Domestic Transportation
Segmentation by Application:
Pharmaceutical Companies
Hospitals
Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
International Transportation
Domestic Transportation
Segmentation by Application:
Pharmaceutical Companies
Hospitals
Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Marken
World Courier
Cryoport
DTW Logistics
City Express
Shanghai Shengsheng Pharmaceutical Cold Chain Technology
Thermo Fisher
SF Express
Catalent
CIMC Cold Cloud
Guoyuan Life Sciences Group
Rochin Logistics
Azenta
Saroute
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Cold Chain Services for Innovative Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Cold Chain Services for Innovative Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Cold Chain Services for Innovative Drug Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Cold Chain Services for Innovative Drug Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Cold Chain Services for Innovative Drug Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Cold Chain Services for Innovative Drug Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Cold Chain Services for Innovative Drug Market-Segmentation by Geography
10 North America
10.1 North America Cold Chain Services for Innovative Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Cold Chain Services for Innovative Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Cold Chain Services for Innovative Drug Production Analysis from 2017-2023
10.4 North America Cold Chain Services for Innovative Drug Consumption Analysis from 2017-2023
10.5 North America Cold Chain Services for Innovative Drug Import and Export from 2017-2023
10.6 North America Cold Chain Services for Innovative Drug Value, Production and Market Share by Type (2017-2023)
10.7 North America Cold Chain Services for Innovative Drug Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Cold Chain Services for Innovative Drug by Country (United States, Canada)
10.8.1 North America Cold Chain Services for Innovative Drug Sales by Country (2017-2023)
10.8.2 North America Cold Chain Services for Innovative Drug Consumption Value by Country (2017-2023)
10.9 North America Cold Chain Services for Innovative Drug Market PEST Analysis
11 Europe
11.1 Europe Cold Chain Services for Innovative Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Cold Chain Services for Innovative Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Cold Chain Services for Innovative Drug Production Analysis from 2017-2023
11.4 Europe Cold Chain Services for Innovative Drug Consumption Analysis from 2017-2023
11.5 Europe Cold Chain Services for Innovative Drug Import and Export from 2017-2023
11.6 Europe Cold Chain Services for Innovative Drug Value, Production and Market Share by Type (2017-2023)
11.7 Europe Cold Chain Services for Innovative Drug Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Cold Chain Services for Innovative Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Cold Chain Services for Innovative Drug Sales by Country (2017-2023)
11.8.2 Europe Cold Chain Services for Innovative Drug Consumption Value by Country (2017-2023)
11.9 Europe Cold Chain Services for Innovative Drug Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Cold Chain Services for Innovative Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Cold Chain Services for Innovative Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Cold Chain Services for Innovative Drug Production Analysis from 2017-2023
12.4 Asia-Pacific Cold Chain Services for Innovative Drug Consumption Analysis from 2017-2023
12.5 Asia-Pacific Cold Chain Services for Innovative Drug Import and Export from 2017-2023
12.6 Asia-Pacific Cold Chain Services for Innovative Drug Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Cold Chain Services for Innovative Drug Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Cold Chain Services for Innovative Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Cold Chain Services for Innovative Drug Sales by Country (2017-2023)
12.8.2 Asia-Pacific Cold Chain Services for Innovative Drug Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Cold Chain Services for Innovative Drug Market PEST Analysis
13 Latin America
13.1 Latin America Cold Chain Services for Innovative Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Cold Chain Services for Innovative Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Cold Chain Services for Innovative Drug Production Analysis from 2017-2023
13.4 Latin America Cold Chain Services for Innovative Drug Consumption Analysis from 2017-2023
13.5 Latin America Cold Chain Services for Innovative Drug Import and Export from 2017-2023
13.6 Latin America Cold Chain Services for Innovative Drug Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Cold Chain Services for Innovative Drug Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Cold Chain Services for Innovative Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Cold Chain Services for Innovative Drug Sales by Country (2017-2023)
13.8.2 Latin America Cold Chain Services for Innovative Drug Consumption Value by Country (2017-2023)
13.9 Latin America Cold Chain Services for Innovative Drug Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Cold Chain Services for Innovative Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Cold Chain Services for Innovative Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Cold Chain Services for Innovative Drug Production Analysis from 2017-2023
14.4 Middle East & Africa Cold Chain Services for Innovative Drug Consumption Analysis from 2017-2023
14.5 Middle East & Africa Cold Chain Services for Innovative Drug Import and Export from 2017-2023
14.6 Middle East & Africa Cold Chain Services for Innovative Drug Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Cold Chain Services for Innovative Drug Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Cold Chain Services for Innovative Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Cold Chain Services for Innovative Drug Sales by Country (2017-2023)
14.8.2 Middle East & Africa Cold Chain Services for Innovative Drug Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Cold Chain Services for Innovative Drug Market PEST Analysis
15 Future Forecast of the Global Cold Chain Services for Innovative Drug Market from 2023-2029
15.1 Future Forecast of the Global Cold Chain Services for Innovative Drug Market from 2023-2029 Segment by Region
15.2 Global Cold Chain Services for Innovative Drug Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Cold Chain Services for Innovative Drug Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source